• Milestone Scientific directors converted USD 465,000 of company loans into common stock, eliminating the outstanding note payable.
• Conversion took effect Aug. 19, 2026 at USD 0.5 per share, a 6.4% premium to the USD 0.47 close.
• Transaction issued 976,870 common shares to the participating directors.
• Move leaves Milestone Scientific with a debt-free balance sheet.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Milestone Scientific Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608260900PRIMZONEFULLFEED9816324) on August 26, 2026, and is solely responsible for the information contained therein.